Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study

Summary Background Clinical trials are needed to assess the clinical benefit of antithrombotic prophylaxis in patients with cancer who are receiving chemotherapy, since these patients are at an increased risk of developing a thromboembolism. We did a trial to assess the clinical benefit of the low-m...

Full description

Saved in:
Bibliographic details
Volume: 10
Main Author: Agnelli, Giancarlo, Prof
Gussoni, Gualberto, MD
Bianchini, Carlo, MD
Verso, Melina, MD
Mandalà, Mario, MD
Cavanna, Luigi, MD
Barni, Sandro, MD
Labianca, Roberto, MD
Buzzi, Franco, MD
Scambia, Giovanni, Prof
Passalacqua, Rodolfo, MD
Ricci, Sergio, MD
Gasparini, Giampietro, MD
Lorusso, Vito
Bonizzoni, Erminio, PhD
Tonato, Maurizio, MD
Format: Journal Article
Language: English
Zielgruppe: Academic
Place of publication: NEW YORK Elsevier Ltd 2009
ELSEVIER SCIENCE INC
Elsevier B.V
published in: The lancet oncology Vol. 10; no. 10; pp. 943 - 949
Related: on behalf of the PROTECHT Investigators
PROTECHT Investigators
ORCID: 0000-0001-7149-822X
Data of publication: 2009
ISSN: 1470-2045
1474-5488
EISSN: 1474-5488
Discipline: Medicine
Subjects:
Online Access: available in Bonn?
Database: Web of Knowledge
Science Citation Index Expanded
Web of Science
Web of Science - Science Citation Index Expanded - 2009
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Academic OneFile (A&I only)
MEDLINE - Academic
Database information Databases - DBIS